Page last updated: 2024-12-06
ammonium sulfite
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
ammonium sulfite: RN given refers to cpd with unspecified MF [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 25041 |
CHEBI ID | 186946 |
MeSH ID | M0138755 |
Synonyms (27)
Synonym |
---|
ammonium sulphite |
ammonium sulfite |
FT-0694833 |
diazanium;sulite |
diammonium sulfite |
10196-04-0 |
CHEBI:186946 |
sulfurous acid, diammonium salt |
ec 233-484-9 |
diammonium sulfonate |
sulfurous acid, ammonium salt (1:2) |
einecs 233-484-9 |
8lf589y5gd , |
unii-8lf589y5gd |
hsdb 1426 |
sulfurous acid, ammonium salt |
ammonium sulfonate |
AKOS015904487 |
sulfurous acid ammonium salt (1:2) |
ammonium sulfite [inci] |
ammonium sulfite [hsdb] |
ammonium sulfite [mi] |
PQUCIEFHOVEZAU-UHFFFAOYSA-N |
ammoniumsulfite |
DTXSID2064991 |
ammoniumsulfit |
diazanium;sulfite |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (2)
Class | Description |
---|---|
p-block molecular entity | A main group molecular entity that contains one or more atoms of a p-block element. |
sulfite salt | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (15)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (6.67) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 5 (33.33) | 24.3611 |
2020's | 3 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 58.27
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (58.27) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (6.67%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (93.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |